StonvexLoading…
StonvexStonvexStonvexCore line items from SF's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-28 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $1.47B | $1.01B | $3.77B | $2.64B | $1.68B |
Operating Income | Not available | $326.07M | $871.14M | $563.23M | $277.18M |
Net Income | Not available | $251.42M | $683.78M | $419.42M | $208.05M |
EPS (Diluted) | $1.40 | $1.48 | $5.87 | $3.56 | $1.73 |
Total Assets | Not available | $42.89B | $41.27B | $41.69B | $39.86B |
Total Liabilities | Not available | $36.91B | $35.29B | $35.93B | $34.26B |
Cash & Equivalents | Not available | $2.90B | $2.25B | $3.18B | $1.86B |
Free Cash Flow OCF − CapEx | Not available | $-390.42M | $1.05B | $685.98M | $364.88M |
Shares Outstanding | Not available | 163.44M | 110.05M | 109.92M | 109.79M |